On the Record · Takeda Pharmaceutical
Takeda Pharmaceutical competitors, on the record
The companies whose own annual reports name Takeda Pharmaceutical as a competitor, each with the sentence it appears in and the filing it came from.
Who Takeda Pharmaceutical names
Takeda Pharmaceutical’s annual reports for 2024 to 2026 describe its competition by kind of business and do not name competing companies.
Who names Takeda Pharmaceutical
Companies whose own annual reports name Takeda Pharmaceutical as a competitor.
Word for word“This segment’s major competitors, including Viatris Inc. (Viatris), Jazz Pharmaceuticals plc (Jazz), Takeda Pharmaceutical Company Limited and Amgen, Inc., among others, vary depending on therapeutic and product category, dosage strength and drug-delivery systems, among other factors.” 10-K for 2024
Word for word“This segment’s major competitors, including Viatris Inc. (Viatris), Jazz Pharmaceuticals plc (Jazz), Takeda Pharmaceutical Company Limited and Amgen, Inc., among others, vary depending on therapeutic and product category, dosage strength and drug-delivery systems, among other factors.” 10-K for 2023
Read from Takeda Pharmaceutical’s annual reports (20-F for 2026, 20-F for 2025, 20-F for 2024) and the financial data it files with the SEC, as of 2026-06-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.